Momentous Therapeutics
Momentous Therapeutics is a startup headquartered in Cambridge, United Kingdom, founded in 2022. It has won about £2.00m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Momentous Therapeutics has won about £2.00m in competitive Innovate UK grants since 2023.
R&D ecosystem
Momentous Therapeutics sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- Coherence Neuro
- Deepform
- Ethicronics
- Inkle
- Kubos Semiconductors
- Neobe Therapeutics
- Panakeia Technologies
- Rapidx Bio
- Reactwise Technologies
- Spotta
- The Vaccine Group
Related
- Innovation profile of Cambridge
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Momentous Therapeutics do?
Momentous Therapeutics works in biotechnology. Its Innovate UK projects include: Developing a transformative pan-cancer drug that unleashes the true potential of I/O.
Where is Momentous Therapeutics based?
Momentous Therapeutics is headquartered in Cambridge, United Kingdom.
When was Momentous Therapeutics founded?
Momentous Therapeutics was founded in 2022.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.